PATENT CLAIM ANALYSIS

Application Number: 15760343
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "211040"]

Abstract:
The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.

Claim (Index 13):
The compound of  claim 2 , wherein L is a bond or a methylene.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 90.0
- Lexical Diversity: 1.17949
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15125911', '15030378', '15566633', '12785665', '15450125']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7761825024930674
- 35 USC 102 Novelty (BERT): 0.5439773776989915
- Combined Prediction Score: 0.7529619900136599
- Mean Citation Score: 318.906982
- Max Citation Score: 380.31046
- Similarity Product: 198.48105884153125

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test